Brief: Novozymes Says 2024 Outlook Of Pro Forma Organic Sales Growth Now Expected At Upper End Of 5-7% Range

Novozymes A/S

17/06/2024 18:13

June 17 (Reuters) - Novozymes A/S  NSISb.CO :
    * 2024 OUTLOOK OF PRO FORMA ORGANIC SALES GROWTH NOW
EXPECTED AT
UPPER END OF 5-7% RANGE
    * FY 2024 PRO FORMA ADJUSTED EBITDA MARGIN INCREASED TO
35-36%
FROM PREVIOUSLY APPROX 35%
    * AN EXPECTED DIVIDEND PAYOUT RATIO OF 40-60%

Source text for Eikon:  ID:nGNE272fX5 
Further company coverage:  NSISb.CO 

 ((Reuters.Briefs@thomsonreuters.com;))